Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 90 shares of common stock on July 31, 2024, to cover tax obligations.
Summary
- On July 31, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 90 shares of common stock.
- The transaction was executed at a price of $0.75 per share.
- This disposal was related to covering tax obligations.
- Following the transaction, Christianson directly owns 294,602 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an insider transaction. It doesn't convey any particularly positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This allows investors to monitor the actions of key personnel and their potential impact on the company's stock.
Stakeholder Impact
- The disposal of shares by an insider could be perceived negatively by some shareholders, although the small number of shares disposed of and the reason for disposal (tax obligations) mitigate this concern.
Key Dates
| Date | Description |
|---|---|
| 07/31/2024 | Date of stock disposal transaction |
| 08/02/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.